Pilot Study: The Effect of Rozerem on Sleep Disturbance After Traumatic Brain Injury

Trial Profile

Pilot Study: The Effect of Rozerem on Sleep Disturbance After Traumatic Brain Injury

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 01 Oct 2015

At a glance

  • Drugs Ramelteon (Primary)
  • Indications Insomnia
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Apr 2013 Planned end date changed from 1 May 2012 to 1 May 2014 as reported by ClinicalTrials.gov.
    • 28 Sep 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top